Mitochondrial homeostasis depends on mitophagy, the programmed degradation of mitochondria. Only a few proteins are known to participate in mitophagy. Here we develop a multidimensional CRISPR-Cas9 genetic screen, using multiple mitophagy reporter systems and pro-mitophagy triggers, and identify numerous components of parkin-dependent mitophagy 1 . Unexpectedly, we find that the adenine nucleotide translocator (ANT) complex is required for mitophagy in several cell types. Whereas pharmacological inhibition of ANT-mediated ADP/ATP exchange promotes mitophagy, genetic ablation of ANT paradoxically suppresses mitophagy. Notably, ANT promotes mitophagy independently of its nucleotide translocase catalytic activity. Instead, the ANT complex is required for inhibition of the presequence translocase TIM23, which leads to stabilization of PINK1, in response to bioenergetic collapse. ANT modulates TIM23 indirectly via interaction with TIM44, which regulates peptide import through TIM23 2 . Mice that lack ANT1 show blunted mitophagy and consequent profound accumulation of aberrant mitochondria. Disease-causing human mutations in ANT1 abrogate binding to TIM44 and TIM23 and inhibit mitophagy. Together, our findings show that ANT is an essential and fundamental mediator of mitophagy in health and disease.
Mitochondrial homeostasis depends on mitophagy, the programmed degradation of mitochondria. Only a few proteins are known to participate in mitophagy. Here we develop a multidimensional CRISPR-Cas9 genetic screen, using multiple mitophagy reporter systems and pro-mitophagy triggers, and identify numerous components of parkin-dependent mitophagy 1 . Unexpectedly, we find that the adenine nucleotide translocator (ANT) complex is required for mitophagy in several cell types. Whereas pharmacological inhibition of ANT-mediated ADP/ATP exchange promotes mitophagy, genetic ablation of ANT paradoxically suppresses mitophagy. Notably, ANT promotes mitophagy independently of its nucleotide translocase catalytic activity. Instead, the ANT complex is required for inhibition of the presequence translocase TIM23, which leads to stabilization of PINK1, in response to bioenergetic collapse. ANT modulates TIM23 indirectly via interaction with TIM44, which regulates peptide import through TIM23 2 . Mice that lack ANT1 show blunted mitophagy and consequent profound accumulation of aberrant mitochondria. Disease-causing human mutations in ANT1 abrogate binding to TIM44 and TIM23 and inhibit mitophagy. Together, our findings show that ANT is an essential and fundamental mediator of mitophagy in health and disease.
We carried out a multidimensional CRISPR-Cas9 genome-wide screen to identify new components of the mitophagy machinery. In the predominant pathway for mitophagy, PTEN-induced kinase 1 (PINK1) accumulates on damaged mitochondria and recruits the E3 ubiquitin ligase parkin to target mitochondria for autophagy 1, 3, 4 . We generated C2C12 mouse myoblasts that stably overexpressed parkin, and induced robust mitophagy by exposing the cells to either of two orthogonal mitochondrial stressors: membrane potential uncoupling with carbonyl cyanide m-chlorophenyl hydrazine (CCCP) or suppression of oxidative phosphorylation with the OAR cocktail of inhibitors (oligomycin inhibiting complex V, antimycin A inhibiting complex III and rotenone inhibiting complex I) (Extended Data Fig. 1a, b ). Cells were transduced with lentivirus containing Cas9 plus guide RNAs (gRNAs) targeting more than 20,000 genes 5 , treated with either CCCP or OAR, and subjected to one of four flow-cytometry-based mitophagy assays: (1) loss of mitotracker labelling of mitochondrial membrane 6 ; (2) loss of ectopically expressed outer-membrane-targeted GFP (GFP-OMP25);
(3) loss of ectopically expressed matrix GFP protein (COX8-GFP); or (4) altered fluorescence of matrix-targeted mKeima from 440 nm to 586 nm as it encounters the low-pH environment of the lysosome 7 ( Fig. 1a, Extended Data Fig. 1c ). High-and low-fluorescence fractions were sorted and subjected to sequencing. gRNA clones that were over-represented in the low-fluorescence fraction identified potential accelerators of mitophagy, and those in the high-fluorescence fraction potential decelerators. In all seven assays, Pink1 gRNAs scored near the top as decelerators of mitophagy, validating the approach (Fig. 1b ). An aggregate Z-score metric placed Pink1 gRNAs as the lead decelerator ( Fig. 1c ). Most proteins that are reported in the Kyoto Encyclopedia of Genes and Genomes (KEGG) Pathway Database (https://www.genome. jp/kegg/) as regulators of mitophagy were identified in the screen (Extended Data Fig. 1d ), supporting the robustness of the screen. The complete results of the screen are provided in Supplementary Table 1 .
Genes whose perturbation accelerates mitophagy have been less investigated than those for which perturbation suppresses it 1, 8, 9 . Unbiased gene set enrichment analysis (GSEA) of gRNAs that accelerate mitophagy identified mitochondrial bioenergetics as the most important target class (Extended Data Fig. 2a ). The analysis identified 16% of genes that encode mitochondrial proteins, a threefold overrepresentation over all genes (Extended Data Fig. 2b ), in particular genes involved in oxidative phosphorylation (OXPHOS) (Extended Article Data Fig. 2c ), consistent with bioenergetic dysfunction being a key promoter of mitophagy. OXPHOS genes were over-represented in each screen (Extended Data Fig. 2d ) and markedly so in aggregate (Extended Data Fig. 2e ). GSEA of decelerators of mitophagy identified a wide range of classes (Extended Data Fig. 2f ). Nearly every component of major complexes known to be required for autophagy was identified, including the endosomal sorting complexes required for transport (ESCRT), the homotypic fusion and vacuole protein sorting (HOPS) complex [10] [11] [12] [13] (Extended Data Fig. 2g , h), and those involved in autophagosome formation (Extended Data Fig. 2i ). Variability among screens was higher between assays than between mitophagy triggers (Extended Data Fig. 2j ), despite the markedly different bioenergetic effects of CCCP and OAR (Extended Data Fig. 2k ), suggesting that different forms of bioenergetic collapse converge on a common mitophagy pathway. Autophagy genes scored only in inner membrane and matrix-based screens (Extended Data Fig. 2j ), consistent with degradation of the outer membrane requiring different machinery 14 . The genes encoding the LC3 receptor TAX1BP1 and its regulatory kinase TBK1 scored highly (Extended Data Fig. 1d ) and were validated with independent gRNAs and orthogonal assays (Extended Data Fig. 3a, b ). Deletion of all five LC3 receptors reduced mitophagy levels as much as did deletion of Pink1 (Extended Data Fig. 3c ), indicating that there is substantial redundancy. Co-deletion of Tax1bp1 and Tbk1 had similar synergistic effects (Extended Data Fig. 3d ).
The ANT, which is located on the inner membrane, mediates transmembrane exchange of ADP and ATP, providing ADP to the mitochondrial ATPase (complex V). ANT is not known to be involved in mitophagy. Strikingly, both Ant1 (also known as Slc25a4) and Ant2 (also known as Slc25a5) scored highly in our screen ( Fig. 1b,c) , and were validated with independent gRNAs (Fig. 1d ) and by orthogonal assay using western blotting to detect degradation of mitochondrial components ( Fig. 1e , Extended Data Fig. 4a ). Deletion of Ant1 or Ant2 in mouse N2A neuroblastoma cells that express endogenous parkin, and deletion of ANT2 in human SH-SY5Y neuroblastoma cells (which express only ANT2), also potently suppressed mitophagy (Extended Data Fig. 4b, c ). Finally, small interfering RNA (siRNA)-mediated suppression of Ant1 or Ant2 in primary rat hippocampal neurons blocked the engulfment of mitochondrial fragments by the autophagy receptor OPTN, a quantifiable marker of mitophagic events in these cells and nonneuronal cell lines 15 (Fig. 1f ). Thus, we find that ANT is required for parkin-mediated mitophagy in numerous cell types.
These observations were unexpected. Blocking ADP/ATP exchange worsens CCCP-induced membrane depolarization (Extended Data Fig. 5a ), and would be predicted to accelerate mitophagy rather than decelerate it 16, 17 . Indeed, pharmacological inhibition of ADP/ATP exchange aggravated mitophagy ( Fig. 2a , Extended Data Fig. 5b ). By contrast, genetic deletion of Ant1 or Ant2 prevented mitophagy, despite worsening the loss of membrane potential after CCCP treatment ( Fig. 2b) . These data indicate that deletion of Ant1 or Ant2 blocks mitophagy via mechanisms other than blocking ADP/ATP exchange. Consistent with this conclusion, ectopic expression of ANT1 with mutations (K43E/R244E) that interfere with binding to ATP 18 and ADP/ATP exchange (Extended Data Fig. 5c , d) rescued mitophagy in cells lacking ANT1 as efficiently as did wild-type ANT1 (Fig. 2c ). By contrast, two mutations, A123D and A90D (identified in patients with cardiomyopathy and external ophthalmoplegia, respectively 19 ), failed to rescue mitophagy ( Fig. 2c ), despite evidence that these mutations preserve ADP/ATP exchange 16 (Extended Data Fig. 5d ). Thus, ANT promotes mitophagy independently of its ADP/ATP exchange activity.
Loss of ANT prevented mitophagy induced by oxidative stress (H 2 O 2 ) and OXPHOS poisons, both PINK1-dependent processes, but not by hypoxia or nutrient deprivation, both PINK1-independent processes (Extended Data Fig. 5e ), suggesting that ANT acts upstream of PINK. In the absence of mitochondrial damage, PINK1 is constitutively degraded by the cytosolic proteasome, after being partly imported into mitochondria through the TIM23 complex; this leads to the proteolytic removal in the matrix of the transmembrane domain of PINK1 and allows its subsequent release to the cytoplasm 20 . When mitochondrial damage occurs, TIM23-mediated translocation is inhibited, causing PINK1 to retain its transmembrane domain, incorporate into the outer membrane, escape degradation, auto-phosphorylate, and recruit parkin to the mitochondria 1, 20, 21 . In the absence of ANT1 or ANT2, however, CCCP did not induce stabilization of PINK1 ( Fig. 2d , Extended Data Fig. 5f ). PINK stabilization could be rescued by wild-type ANT1 or ANT1(K43E/R244E), but not by ANT1(A90D) or ANT1(A123D) (Extended Data Fig. 5g ). Autophosphorylation (Extended Data Fig. 5h ), mRNA expression (Extended Data Fig. 5i ), or protein translation (Extended Data Fig. 5j ) of PINK1 were not affected by the absence of ANT. PARL or OMA1-proteases that are involved in PINK1 processing 22, 23 (Extended Data Fig. 5k ) and general autophagy (Extended Data Fig. 5l )-were similarly unaffected. By contrast, in cells lacking Ant1 or Ant2, CCCPtriggered suppression of TIM23-mediated protein translocation into the matrix (Extended Data Fig. 5m ) and cleavage in the matrix of imported Su9-DHFR precursor (p) to the mature (m) form ( Fig. 2e ) were markedly blunted, indicating that ANT1 or ANT2 is required for suppression of TIM23. The loss of ANT1 and ANT2 did not affect the integrity of the TIM23 or TOM megacomplexes (Extended Data Fig. 6a ). ANT1 and ANT2 interact with TIM23 (Extended Data Fig. 6b, c) , as does the ATP-binding mutant ANT1(K43E/R244E), but the disease-causing mutants ANT1(A90D) and ANT1(A123D) do not (Extended Data Fig. 6d ). ANT1(K43E/R244E) rescued the suppression of TIM23 in cells lacking ANT1, but ANT1(A90D) and ANT1(A123D) did not (Extended Data Fig. 6e ). Together, these data show that ANT mediates the suppression of TIM23 translocase in response to the collapse of mitochondrial bioenergetics by interacting with TIM23, independently of its activity as an ADP/ATP exchange carrier.
To understand how ANT interacts with TIM23, we probed a mitochondrial interactome database 24 and identified TIM44 as a leading candidate interactor with ANT1 ( Fig. 2f ). TIM44 is a matrix-side component of the TIM23 complex that controls the translocation of polypeptides across TIM23 2 . TIM44 co-immunoprecipitated with ANT1 and ANT2 (Extended Data Fig. 6b , f). Knockout of TIM44 abrogated binding of TIM23 to ANT1 (Fig. 2g ), indicating that TIM44 is likely to mediate the TIM23-ANT1 interaction. Like loss of ANT1, loss of TIM44 blunted both mitophagy (Extended Data Fig. 6g ) and accumulation of PINK1 (Extended Data Fig. 6h ). A mutant of ANT1 that cannot bind to TIM44 (ANT1(G146E/K147D); Fig. 2h ) failed to rescue mitophagy in cells lacking ANT1 (Extended Data Fig. 6i ). Notably, the diseasecausing mutant ANT1(A90D) also disrupted interaction with TIM44 ( Fig. 2h ). Conversely, a mutant of TIM44 that cannot bind to ANT1 (TIM44(K282D); Extended Data Fig. 6j ) failed to rescue mitophagy in cells lacking TIM44 (Extended Data Fig. 6k ), despite preserved ability to bind to TIM23 itself (Extended Data Fig. 6l ). Together, these data show that ANT1 interacts with TIM44, a regulator of TIM23-mediated protein translocation 2 , and that the interaction of ANT1 with TIM44 is required for the ANT1-TIM23 interaction, for suppression of TIM23mediated protein translocation in response to bioenergetics collapse, and for the promotion of mitophagy ( Fig. 2i ).
To test whether ANT is required for mitophagy in vivo, we examined mice lacking Ant1 25 (Ant1 KO mice). Mitochondria isolated from the heart or brain of Ant1 KO mice accumulated remarkably less PINK1 and parkin than mitochondria from littermate controls, despite showing equivalent or higher amounts of transcription of PINK1 and parkin ( Fig. 3a, Extended Data Fig. 7) . Similarly, expression in skeletal muscle of mitochondria-targeted tandem GFP-mCherry (mito QC, which allows quantification of lysosome-targeted mitochondria as red-only punctae 26, 27 ) revealed a profound defect in mitophagy in Ant1 KO mice (Fig. 3b ). Muscle mitophagy was rescued by re-expression of wild-type ANT1 or ANT1 bearing a K33Q mutation, which is found in patients with Article mild muscular disease despite complete loss of ADP/ATP exchange capacity 28 (Extended Data Fig. 5d ), but was not rescued by expression of ANT1(A90D), which is found in patients with severe disease but normal ADP/ATP exchange (Fig. 3c, Extended Data Fig. 5d ). Consistent with defective mitophagy, the heart and skeletal muscle of Ant1 KO mice revealed marked accumulation of mitochondria, as shown by mitochondrial DNA (Fig. 3d ) and protein (Fig. 3e ), electron microscopy (Fig. 3f) , and deep colouring of skeletal muscle 29 (Fig. 3g) . Notably, the expression of nuclear-encoded mitochondrial genes was unaffected in Ant1 KO mice (Fig. 3d) , indicating that the accumulation of mitochondria occurs without mitochondrial biogenesis. Moreover, the accumulated mitochondria are profoundly abnormal, with swelling, loss of architecture and density of cristae (Fig. 3f) , and accumulated DNA mutations [30] [31] [32] , all consistent with a loss of quality control and clearance caused by absence of mitophagy. These numerous abnormalities lead to marked cardiac hypertrophy 29 and loss of normal contractile function (Fig. 3h) .
Finally, to evaluate the consequences of loss of ANT1 in human cardiac tissue, we identified a patient bearing homozygous lossof-function mutations in ANT1 (frameshift at position 522, p.Y174fs) in the Penn Medicine BioBank (PMBB). The patient developed severe non-ischaemic cardiomyopathy with biventricular failure, with a left ventricular ejection fraction of about 15% (normal is about 55%; Fig. 3i ). Endomyocardial biopsy revealed profound mitochondrial abnormalities, including swelling, loss of cristae, and diffuse burst mitochondria with compromised outer membranes and release of mitochondrial components into the cytoplasm, all consistent with loss of mitophagy and mitochondrial quality control (Fig. 3j) .
In summary, we have shown that ANT is critically required for mitophagy in cell culture and in vivo; that ANT interacts with TIM23 and is required for suppression of TIM23-mediated protein translocation and subsequent stabilization of PINK1; that ANT modulates TIM23 via interaction with TIM44, a known regulator of TIM23 polypeptide import; and that this role for ANT in mitophagy is independent of its ADP/ATP exchange capacity. ANT is ideally positioned, as a proton gradient-dependent carrier of ADP/ATP, to sense bioenergetic failure from either proton gradient collapse (for example, with CCCP) or failure to carry out oxidative phosphorylation (for example, with OAR). Mutations in ANT1 cause diseases ranging from cardiomyopathy (A123D) to progressive external ophthalmoplegia (A90D), but the underlying mechanisms of these conditions are still debated. These diseases typically manifest a high burden of mitochondrial DNA mutations 31, 33 , suggesting a failure of adequate mitochondrial quality control. In addition, there is poor correlation between ADP/ATP exchange capacity and disease severity 34 . Our data thus suggest that defects in mitophagy, rather than in ADP/ATP exchange, may drive the pathophysiology of ANT1-associated diseases.
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Methods

Cells
C2C12 myoblasts, SH-SY5Y neuroblastoma cells, N2A neuroblastoma, and Lenti-X 293T cells were cultured at 37 °C with 5% CO 2 in Dulbecco's modified Eagle's medium (DMEM, Invitrogen) containing 10% fetal bovine serum (HyClone) and penicillin/streptomycin (100 U/ml, Invitrogen). C2C12, SH-SY5Y, N2A cells were purchased from ATCC, and Lenti-X 293T cells were from Clontech. No commonly misidentified cell line was used in this study. All the cell lines were routinely tested negative for mycoplasma contamination.
Mice
All mouse experiments were performed according to procedures approved by the University of Pennsylvania Institutional Animal Care and Use Committees. Male Ant1−/− and Ant1+/+ mice (C57BL/6JEiJ) were fed a standard diet ad libitum. Mice were maintained on a 13:11 h light-dark cycle. Mitophagy was assessed with mito-QC plasmid injection in male 12-16 week-old mice, and echocardiography was performed in male 8-9 month-old mice.
Antibodies
The following primary antibodies were used: mouse anti-HA (clone 6E2, CST, 1:2,000), rabbit anti-HA (clone C29F4, CST, 1:1,000), anti-HA (HRP Conjugate, clone C29F4, CST, 14031S, 1:5,000), anti-DYK-DDDDK Tag (clone D6W5B, 14793S, CST, 1:5,000), anti-Flag (clone M2, sigma, F3165, 1:5,000), anti-Tom20 (FL-145, Santa Cruz Biotechnology, 1:2,000 for immunoblotting or 1:200 for immunostaining), anti-Tom70 (Proteintech, 1:1,000), anti-ATPB (clone 3D5, Abcam, 1:1,000), anti-ATPA (7H10BD4F9, Invitrogen, 1:2,000), anti-Pyruvate dehydrogenase E2/E3bp (clone 13G2AE2BH5, Abcam, 1:1,000), antibeta actin (clone 13E5, CST, 1:2,000), anti-ANT1 (Sigma, SAB4300887, 1:1,000), anti-ANT1 (Sigma, SAB2108761, 1:1,000), anti-ANT2 (Sigma, HPA046835, 1:1,000), anti-Timm23 (Abcam, ab116329, 1:1,000), anti-Timm23 (Proteintech, #11123, rabbit, 1:1,000), anti-Timm22 (Proteintech, 14927-1-AP, rabbit, 1:1,000), anti-VDAC1 (CST, #4866S, rabbit, 1:2,000), anti-Pink1 (Caymanchem, #10006283, rabbit, 1:500), antiparkin (Santa Cruz, PRK8, sc-32282 HRP, mouse, 1:100), anti-p62 (CST, #5114S, rabbit, 1:2,000), anti-OPA1 (BD, #612607, mouse, 1:5,000), anti-PGAM5 (Abcam, ab126534, rabbit, 1:1,000), anti-Tomm40 (Proteintech, #18409, rabbit, 1:5,000), anti-GAPDH (CST, #5174S, rabbit, 1:5,000), anti-Tubulin (CST, #2128S, rabbit, 1:5,000), anti-beta actin (CST, #4970S, rabbit, 1:2,000), anti-pan actin (CST, #8456S, rabbit, 1:5,000). We also used the following secondary antibodies: antimouse-IgG or anti-rabbit-IgG antibody conjugated to horseradish peroxidase (CST, 1:5,000) for immunoblotting, and anti-rabbit-IgG antibody conjugated to Alexa Fluor 594 (Life Technologies, 1:2,000) for immunostaining.
Plasmids
Individual gRNAs were cloned into lentiCRISPR v2 (Addgene 52961) or lentiGuide-Puro (Addgene 52963) 35 and cDNAs were cloned in pLenti (Addgene 22255), pMSCV (Clontech), or pcDNA4TO (Addgene 60914). Drug resistance genes in lentiGuide, pLenti, and pMSCV were replaced by Neomycin or Zeocin resistant genes. The resulting plasmid was verified by sequencing. pMD2.G (Addgene 12259) and psPAX2 (Addgene 12260) were used for lentiviral packaging. pMD2.G and gag/pol (Addgene 14887) were used for retroviral packaging.
Gene-specific cDNA rescue
A gRNA-resistant version of ANT1 was amplified by the primer encoding silent mutations within the gRNA recognition sites. This cDNA was cloned into pMSCV-neo for cell experiments and pAAV-CMV for in vivo mitophagy measurements.
Virus production
To produce lentivirus for the screen, we used the GeCKOv2mouse library in the lentiGuide-Puro vector 35 . Ten-centimetre plates of 70% confluent Lenti-X 293T (Clontech) cells were transfected with 9 μg of the plasmid library, 6 μg of psPAX2 vector and 3 μg pMD2.G using Fugene HD (Promega) according to the manufacturer's instructions. Supernatant was collected after 48 h and then spun for 10 min at 4 °C at 3,000 rpm and then filtered with a 0.45 μm low protein-binding filter (SFCA) and concentrated by ultracentrifugation for 2 h at 24,000 rpm using SW28Ti. The virus was aliquoted and frozen at -80 °C. The titre of the virus was determined by using C2C12 cells followed by puromycin selection. For other viruses, 6-well plates of 70% confluent Lenti-X 293T cells were transfected with 1.5 μg of transfer vector, 0.5 μg pMD2.G and 1.0 μg of psPAX2 for lentivirus or 1.0 μg of gag/pol for retrovirus using Fugene HD. Supernatant was collected after 48 h and frozen at -80 °C.
CRISPR library cell preparation
C2C12 cells were first infected with lentiviruses prepared from pLenti hparkin and pFUGW spCas9 (Addgene 52962) with 8 μg/ml polybrene. 24 h after infection, cells were treated with 2 mg/ml Hygromycin (Mediatech) and 10 μg/ml Blastcidin (Invitrogen) for 4 days and maintained for 1 week without drugs. Several single-cell clones were developed and tested for the ability to induce mitophagy. The well-induced clone was expanded and additionally infected with lentivirus prepared from pLenti Cox8-GFP, pLenti GFP-Omp25, or pLenti Cox4-mKeima, and then GFP or mKeima positive cells were sorted with narrow signal range. These cells were subsequently infected with the genome-wide GeCKO lentiviral library (Addgene 1000000053) at a multiplicity of infection (MOI) of ~0.5 (to yield ~100 cells per gRNA) with 8 μg/ml polybrene in 6-well plates, with 0.6x10 6 cells infected per well. Infected cells were treated with 2.5 μg/ml puromycin (Clontech) for 4 days, and the cells were expanded for an additional 6 days without puromycin. All virus infection was performed by centrifugation at 1000g for 90 min, then the medium was removed, and cells were incubated in fresh medium for 24 h.
Mitophagy induction
To induce mitophagy, mitochondrial depolarization or inhibition of OXPHOS was induced in human parkin-expressing cells. In the screen, cells were treated with 13 μM CCCP (Sigma) or cocktail of 1.0 μg/ml Oligomycin (Sigma), 1.0 μg/ml Antimycin A (Sigma) and 100 nM Rotenone (Sigma) for 16 h for mild induction of mitophagy to harvest enough cells in low induction population. In other experiments, cells were treated with 15 or 20 μM CCCP (MCE or Sigma) or cocktail of 3 μg/ml Oligomycin and 3 μg/mL Antimycin A.
Fluorescence-activated cell sorting
Cell sorting was performed by BD FACSJazz and BD Influx (BD Biosciences). After mitophagy induction, cells were harvested by trypsinization, washed and resuspened with FACS buffer (PBS containing 2% FBS and 20 mM HEPES). For sorting by MitoTracker, cells were incubated with 100 nM MitoTracker Green FM (CST) for 20 min after mitophagy induction. Cells were sorted into two bins (low and high). The bin boundaries were guided by our observations with or without mitophagy induction in MitoTracker-guided sorting. In other sorting, there was no clear separation between high and low populations. Two bins were set to sort the top 25-30% and bottom 25-30%. Measurements of lysosomal mt-mKeima were made using dual-excitation ratiometric pH measurements at 488 nm (pH 7) and 532 nm (pH 4) lasers with 670/30 nm and 583/40 nm emission filters, respectively. In each library, ~40 million cells were sorted and ~10 million cells were collected in each bin. For non-pooled CRISPR knockout experiments with individual gRNAs, BD LSR II (BD Biosciences) and Attune NxT Flow Cytometer (Thermo Fisher Scientific) were used. Analysis was done with FlowJo (Treestar).
Article
DNA purification, library preparation, and sequencing
Genomic DNA from sorted cells was purified and eluted in 500 μl H 2 O using Blood and Cell Culture DNA Midi kit (Qiagen) according to the manufacturer's instruction. More than 100 μg of DNA were typically obtained from the analyses. We performed 3-step PCR reactions using TaKaRa Ex Taq and PrimeSTAR HS (Clontech). The first PCR was the enrichment of gRNA sequence from 100 μg extracted gDNA in 1 ml reaction. The 2nd and 3rd PCRs were to attach Illumina sequencing adapters and sample barcodes with 1-5 μl from the prior PCR. PCR cycling conditions were 2 min at 98 °C; followed by 25 cycles (1st PCR) or 7 cycles (2nd and 3rd PCRs) of 10 s at 98 °C, 15 s at 55 °C, 60 s at 72 °C; and a final 2 min extension at 72 °C. The final PCR product was run on a 2% agarose gel and the right size fragment was extracted with QIAquick Gel Extraction kit (Qiagen). Samples were sequenced on a HiSeq 2500 (Illumina). gRNA reads were mapped to a reference index of all GeCKO mouse library gRNA sequences using the short read aligned STAR 36 and the following parameters (-outFilterMultimapNmax 41-outFilterMis-matchNmax 4-outFilterScoreMinOverLread 0-outFilterMatchNmi-nOverLread 0-outFilterMatchNmin 17). Uniquely mapped reads were counted for each gRNA for each sample.
Screen statistical analysis
To determine the enrichment of gRNAs between treatment and control, we used the Z score method 37 . In brief, count data were quantile normalized per replicate to adjust for differences in library sizes. Replicates were summarized on the gRNA guide level using a geometric mean and a fold change was computed between the treatment and the control. To summarize at the gene level, the mean of the top four ranked gRNAs was taken for positive regulators, and the bottom four ranked gRNAs for negative regulators. Empirical P values were calculated by randomly assigning gRNAs to genes and false discovery rates (FDR) were assessed using the Benjamini and Hochberg method.
Individual gRNAs validation
The best gRNA from the GeCKO library and one or more non-library gRNAs were cloned into lentiGuide-Puro plasmid (Addgene 52963). Non-library gRNA was designed at http://crispr.mit.edu/. Two nontargeting control in GeCKO library were used as a negative control.
Mitochondrial isolation and immunoprecipitation
Cells were harvested in PBS and washed using isolation buffer (250 mM sucrose, 10 mM HEPES: pH 7.4, 1 mM EGTA). Cells in isolation buffer were homogenized on ice using a Glass Pestle Tissue Grinder (Corning). Cell debris was removed by centrifugation at 1,000g for 10 min. Mitochondria were collected by centrifugation at 10,000g for 10 min 38 . Freshly isolated mitochondria were washed in isolation buffer and protein concentrations were determined by bicinchoninic acid protein assay. Standard immunoprecipitation experiments were performed with 0.5-1 mg mitochondria and analysed by SDS-PAGE and immunoblot analysis. In brief, isolated mitochondria from control cells (empty vector) and cells expressing HA-tagged proteins were solubilized in digitonin-containing buffer (1% [w/v] digitonin, 20 mM Tris, pH 7.5, 0.1 mM EDTA, 50 mM NaCl, 10% [w/v] glycerol) supplemented with 1× complete protease inhibitor (Roche) at 2 mg/ml end over end on a rotary wheel for 30-60 min at 4 °C. The mitochondrial lysate was cleared by centrifugation at 16,000g at 4 °C for 10 min and diluted in solubilization buffer (20 mM Tris, pH 7.5, 0.1 mM EDTA, 50 mM NaCl, 10% [w/v] glycerol, 1× complete protease inhibitor) so that a final digitonin concentration of 0.5% was achieved. The cleared lysates were applied to pre-equilibrated anti-HA Magnetic Beads (Thermo Fisher Science) and incubated at 4 °C for 60 min under mild agitation. The anti-HA beads and bound proteins were washed × 3 in digitonin-containing buffer (0.1% digitonin [w/v], 20 mM Tris, pH 7.5, 0.1 mM EDTA, 50 mM NaCl, 10% [w/v] glycerol, 1× complete protease inhibitor). Bound proteins were eluted with 2× Laemmli Sample Buffer, then electrophoretically separated using SDS-PAGE 39 .
Phos-tag SDS-PAGE and immunoblotting
To detect phosphorylated proteins, SDS-PAGE with Phos-tag acrylamide gels (Wako chemicals) were used. After electrophoresis, Phos-tag acrylamide gels were washed using transfer buffer with 5 mM EDTA for 10 min with gentle shaking and then replaced with transfer buffer without EDTA for 10 min according to the manufacturer's protocol. Proteins were transferred to PVDF membranes and detected by the indicated antibodies using standard immunoblotting procedures 40 .
ΔΨ measurements
Mitochondrial membrane potential was determined by TMRE according to previous report 41 . In brief, TMRE measurements were performed by LSM 710 confocal laser scanning microscopy (Carl Zeiss Inc.) with the application of live time-series program and using a 20× objective with low-resolution (512 × 512) and attenuated laser power (1%) to avoid photobleaching. Cells were incubated with 40 nM TMRE in Tyrode's buffer (TB: 145 mM NaCl, 5 mM KCl, 10 mM glucose, 1.5 mM CaCl 2 , 1 mM MgCl 2 , and 10 mM HEPES; adjust pH to 7.4 with NaOH) for 30 min before imaging and treatment. We used the region of interest (ROI) tool from the LSM program to select areas and selected ROIs from the entire cell body in imaged cells to measure the TMRE intensity per cell. We calculated the average fluorescence intensities from whole cell bodies for all imaged cells for each time point.
In vivo mitophagy measurements
Mice (Ant1 knockout and wild-type) were anaesthetized with 1-4% isoflurane. A small incision was made on the skin to expose the TA muscle. Twenty-five micrograms of mitoQC plasmid dissolved in sterile saline was intramuscularly injected with a 33G needle attached to a Hamilton syringe. For the co-transfection experiment, 20 μg mitoQC and 5 μg pcDNA3-Luciferase or Ant1 (WT, K33Q or A90D) were injected. The skin incision was then sutured and an electric pulse (voltage, 50 V/cm; pulse duration, 100 ms; frequency of pulses, 1 Hz) was applied by two pin electrodes. A train of eight pulses (four pulses, then an additional four pulses after switching the position of the electrodes) was delivered. Mice were rested for more than 10 days. Then mice were killed and TA muscles were fixed with 4% PFA overnight. For cryoprotection, fixed muscles were then submerged in 30% sucrose/PBS until the tissue pieces sunk. Tissues were then mounted with OCT compound and frozen in 2-methyl butane chilled with liquid N 2 . Tissue blocks were longitudinally sectioned and mounted with DAPI-containing mounting medium. Transfected fibres were searched by GFP signal and confocal images were taken. Each fibre was analysed by Image J. In brief, the confocal image was spitted into green and red channels and bright objects in each channel were identified by local thresholding algorithm (Phansalker) and a binary image of respective objects was created. Red objects touching green objects were subtracted. Size filtering (<0.15 μm 2 ) was applied to filter out the noise. Remaining red objects were counted by particle analysis. The number of red objects was normalized by fibre area.
Electron microscopy
For EM studies, the gastrocnemius was isolated, and red and white fibres were immediately dissected and fixed with 2.5% (vol/vol) glutaraldehyde, 2.0% (vol/vol) paraformaldehyde in 0.1 M sodium cacodylate buffer, pH 7.4, overnight at 4 °C. EM studies were performed on a JEM-1010 microscope at the University of Pennsylvania Electron Microscopy Resource Laboratory.
Constructs and siRNA
The following constructs were used: Mito-DsRed2 (provided by T. Schwarz, Harvard Medical School, Boston) was recloned into a SNAP-Tag vector, and pEGFP-OPTN (provided by I. Dikic, Goethe University, Frankfurt). The following Dharmacon siRNA oligos were used: rat ANT1/Slc25a4 siRNA ON-TARGETPlus SMARTpool, rat ANT2/Slc25a5 siRNA ON-TARGETPlus SMARTpool, and fluorescent ON-TARGETPlus Nontargeting siRNA with 5′ Cy5.
Primary hippocampal culture
Rat hippocampal neurons at embryonic day (E)18, were obtained from the Neurons R Us Culture Service Center through the Penn Medicine Translational Neuroscience Center at the University of Pennsylvania. Cells were plated at density of 250,000 neurons per 35-mm glass-bottom MatTek dish that were precoated with 0.5 ml/ml poly-l-lysine for 24 h. Neurons were maintained in maintenance medium (MM; neurobasal supplemented with 100 units/ml penicillin, 100 μg/ml streptomycin, 2 mM GlutaMax, and 2% B27) at 37 °C in a 5% CO 2 incubator. AraC (5 μM) was added the day after plating.
Neuronal mitophagy assay
After 7 days in vitro (DIV), siRNA (45 pmol) and DNA constructs (0.3 μg Mito-SNAP and 0.4 pEGFP-OPTN) were transfected using Lipofectamine 2000 and incubated for 36-48 h. Prior to imaging, neurons were treated for 2 h with control or 3 nM Antimycin A and labelled with 2 μM SNAP Blue 430 (Promega). After 1.5 h of incubation, cells were quickly washed twice with MM to remove excess SNAP label and incubated for 30 min in control and Antimycin A media plus 2.5 nM TMRE. For live-cell imaging, neurons were placed in HibernateE supplemented with 2% B27 and 33 mM d-glucose; 3 nM Antimycin A was added to the imaging medium for treated conditions. Neurons were imaged in an environmental chamber at 37 °C on a Perkin Elmer UltraView Vox spinning disk confocal on a Nikon Eclipse Ti Microscope with a × 1.49 NA oil-immersion objective and a Hamamatsu EMCCD C9100-50 camera driven by Volocity. Z-stacks of the soma were acquired at 150 nm step-size. For mitophagy analysis, the number of clearly defined OPTN rings around damaged, spherical mitochondria was counted for each cell. The percentage of cells with mitophagy events was quantified and plotted in GraphPad Prism. Statistical analysis was carried on data sets that were performed from more than four independent preparations. One-way ANOVA tests with Dunnett's post hoc test were performed where values were compared to the control siRNA with 2 h Antimycin A treatment.
Penn Medicine BioBank
The Penn Medicine BioBank (PMBB) is a longitudinal genomics and precision medicine study, in which participants consent to linkage of biologic specimens with electronic health record data. Currently, more than 50,000 participants are enrolled. The study was approved by the Institutional Review Board of the University of Pennsylvania. ADP/ATP exchange rate ADP/ATP exchange rate by magnesium green (Invitrogen) was determined in permeabilized myotubes as described previously 42 . In brief, ANT1 knockout C2C12 myoblasts were infected with wild type ANT1, ANT1(K33Q), ANT1(K43E), ANT1(A90D), ANT1(V289M) or ANT1(A114P) encoding retrovirus. C2C12 myoblasts were induced to differentiate into myotubes by replacing culture medium with differentiation medium containing DMEM and 2% horse serum. Myotubes were processed on the 6th day for subsequent experiments. Cells were resuspended in a buffer containing 8 mM KCl, 110 mM K-gluconate, 10 mM NaCl,10 mM Hepes, 10 mM KH 2 PO 4 , 0.005 mM EGTA, 10 mM mannitol, 0.5 mM MgCl 2 . Digitonin and MgG 5 K + salt were subsequently added. MgG fluorescence and recorded at a 0.33-Hz acquisition rate by using 505 and 535 nm excitation and emission wavelengths, respectively. Mitochondrial phosphorylation was started by the addition of 2 mM ADP was recorded for 20 min. Minimum fluorescence was measured by the addition of 5 mM EDTA, and maximum fluorescence was measured by the addition of 10 mM MgCl 2 . ADP-ATP exchange rates were calculated by linear regression of the magnesium green fluorescence calibrated and converted to ATP appearing in the medium 42 .
In vitro transcription and translation
Before being imported into purified mitochondria, [ 35 S]-methionine labelled precursor protein was generated with TNT Quick Coupled Transcription/Translation kit (Promega) and TRAN35S-LABEL, Metabolic Labelling Reagent (MP Biomedicals).
Import of radiolabelled proteins into mitochondria
Ten micrograms of C2C12 cell mitochondria were incubated in import buffer (20 mM HEPES pH 7.4, 220 mM mannitol, 70 mM sucrose, 1 mM ATP, 0.5 mM magnesium acetate, 20 mM sodium succinate, 5 mM NADH) for 5 min at 25 °C. The membrane potential was disrupted by treatment with 20 μM CCCP (MCE). After adding 10 μl precursor, mitochondria were cultured for 10 min at 25 °C. Samples were transferred to ice and 500 μl cold homogenization buffer was added. Trypsin was added to a final concentration of 10 μg/ml, and samples were incubated on ice for an additional 15 min. The trypsin digestion was terminated by adding soybean trypsin inhibitor to a final concentration of 250 μg/ml. Mitochondria were re-isolated by centrifugation at 10,000g for 5 min. Samples were resuspended in SDS sample buffer and resolved by SDS-PAGE.
Blue native PAGE
Mitochondria were isolated from indicated C2C12 myoblasts and were lysed in BN lysis buffer (20 mM HEPES pH 7.4, 50 mM NaCl, 2.5 mM MgCl 2 , 10% glycerol, 0.1 mM EDTA, 0.5 mM PMSF, 1.5% or 0.5% digitonin; AG scientific) at a concentration of 5 mg/ml for 30 min on ice. After a centrifugation at 21,000g for 10 min the mitochondrial extract was separated on NativePAGE 3-12% Bis-Tris Gels (Invitrogen) or Precast-Glgel 4-15% Native PAGE Gels (Sangon Biotech). Proteins were transferred to a PVDF membrane and detected by immunoblot using the indicated antibodies.
Statistical analyses
All data were expressed as mean ± s.d. No statistical methods were used to predetermine sample size. Sample size was based on experimental feasibility and sample availability. Randomization was not applicable to mouse studies owing to genotype-dependent analyses. Samples were processed in random order and mitophagy signal count, heart weight and echocardiography were measured in a blinded manner. Comparisons between the two groups were analysed using the twosided unpaired t-test. One-way ANOVA followed by Tukey's post hoc test, or post hoc Dunnett's multiple comparison test was used for multiple group comparisons. Two-way repeated measures ANOVA was used for the comparisons in TMRE membrane potential experiments; P < 0.05 was considered statistically significant.
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Statistics
For all statistical analyses, confirm that the following items are present in the figure legend, table legend, main text, or Methods section.
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement A statement on whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one-or two-sided Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistical parameters including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted Our web collection on statistics for biologists contains articles on many of the points above.
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Data collection
Western blot densitometry data were collected by GE Healthcare ImageQuant 400 Biomolecular Imager, or BioRad Molecular Imager ChemiDoc XRS+ with Image Lab Software 4.0., flow cytometry data by BD FACSDiva software, confocal microscopy data by ZEN Black Edition software, qPCR by BioRad CFX384 RealTime System and BioRad CFX Manager 3.1., NGS by illumina HiSeq2500.
Data analysis gRNA reads were mapped to a reference index of all GeCKO mouse library gRNA sequences using the short read aligned STAR code. The Z score method was used to determine the enrichment of gRNAs between treatment and control. Flow cytometry data analysis was performed using FlowJo V10 (Treestar), confocal microscopy data analysis using ZEN Black Edition software, and most image processing and analysis was done using FIJI. All other data analyses were performed using GraphPad Prism 8 (GraphPad Software).
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
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